Affluent Medical SA (EPA: AFME)
France
· Delayed Price · Currency is EUR 1.220
-0.300 (-19.74%)
Dec 3, 2024, 3:08 PM CET
Affluent Medical Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Other Revenue | 1.3 | 1.22 | 1.34 | 1.45 | 0.82 | 1.43 | Upgrade
|
| Revenue | 1.3 | 1.22 | 1.34 | 1.45 | 0.82 | 1.43 | Upgrade
|
| Revenue Growth (YoY) | 5.80% | -8.59% | -7.72% | 76.09% | -42.34% | 116.19% | Upgrade
|
| Cost of Revenue | 2.35 | 2.42 | 2.68 | 2.74 | 3.26 | 5.57 | Upgrade
|
| Gross Profit | -1.05 | -1.2 | -1.34 | -1.29 | -2.44 | -4.14 | Upgrade
|
| Selling, General & Admin | 13.41 | 11.87 | 10.55 | 9.68 | 8.11 | 7.42 | Upgrade
|
| Other Operating Expenses | -0.08 | -0.08 | 0.06 | -0.04 | 0.02 | 0.02 | Upgrade
|
| Operating Expenses | 15.74 | 14.2 | 13.05 | 12.06 | 10.03 | 9.7 | Upgrade
|
| Operating Income | -16.79 | -15.4 | -14.39 | -13.35 | -12.47 | -13.84 | Upgrade
|
| Interest Expense | -0.46 | -0.39 | -1.06 | -3.04 | -2.13 | -1.88 | Upgrade
|
| Earnings From Equity Investments | - | - | - | -0.01 | -0.4 | -1.19 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.01 | - | - | - | 0 | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.04 | -0.01 | -0.05 | 1.03 | 0.59 | 0.12 | Upgrade
|
| EBT Excluding Unusual Items | -17.2 | -15.8 | -15.5 | -15.38 | -14.4 | -16.8 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -0.02 | 0.02 | - | - | Upgrade
|
| Legal Settlements | 0.01 | - | 0.12 | 0.1 | -0.13 | - | Upgrade
|
| Pretax Income | -17.19 | -15.8 | -15.4 | -15.26 | -14.53 | -16.8 | Upgrade
|
| Income Tax Expense | -0.15 | -0.15 | -0.17 | -0.44 | -0.21 | -0.21 | Upgrade
|
| Net Income | -17.04 | -15.65 | -15.23 | -14.82 | -14.32 | -16.59 | Upgrade
|
| Net Income to Common | -17.04 | -15.65 | -15.23 | -14.82 | -14.32 | -16.59 | Upgrade
|
| Shares Outstanding (Basic) | 32 | 29 | 19 | 17 | 13 | 12 | Upgrade
|
| Shares Outstanding (Diluted) | 32 | 29 | 19 | 17 | 13 | 12 | Upgrade
|
| Shares Change (YoY) | 35.96% | 54.03% | 11.93% | 26.30% | 12.27% | - | Upgrade
|
| EPS (Basic) | -0.53 | -0.54 | -0.81 | -0.88 | -1.07 | -1.39 | Upgrade
|
| EPS (Diluted) | -0.54 | -0.54 | -0.81 | -0.88 | -1.07 | -1.39 | Upgrade
|
| Free Cash Flow | -7.44 | -12.23 | -11.23 | -12.7 | -9.24 | -11.61 | Upgrade
|
| Free Cash Flow Per Share | -0.23 | -0.42 | -0.59 | -0.75 | -0.69 | -0.98 | Upgrade
|
| Gross Margin | -81.31% | -98.04% | -99.85% | -88.90% | -295.63% | -289.71% | Upgrade
|
| Operating Margin | -1296.60% | -1258.01% | -1074.61% | -920.12% | -1513.23% | -968.51% | Upgrade
|
| Profit Margin | -1315.91% | -1278.84% | -1137.19% | -1021.36% | -1737.74% | -1160.88% | Upgrade
|
| Free Cash Flow Margin | -574.44% | -998.77% | -838.46% | -875.12% | -1121.36% | -812.32% | Upgrade
|
| EBITDA | -14.75 | -13.34 | -12.33 | -11.26 | -10.82 | -11.8 | Upgrade
|
| D&A For EBITDA | 2.05 | 2.06 | 2.06 | 2.09 | 1.65 | 2.04 | Upgrade
|
| EBIT | -16.79 | -15.4 | -14.39 | -13.35 | -12.47 | -13.84 | Upgrade
|
| Advertising Expenses | - | 0.08 | 0.08 | 0.05 | 0.02 | 0.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.